Get started
Author

Anna‐Lena Kraeft

Observed names: A-L Kraeft, A-L. Kraeft, A. Kraeft, A.-L. Kraeft, Anna-Lena KRAEFT, Anna-Lena Kraeft, Anna–Lena Kraeft, Kraeft Anna-Lena
ORCID: 0000-0002-4879-0924
Observed ORCID: 0000-0002-4879-0924
OpenAlex ID: A5085707300
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)
2021 · Gunnar Folprecht, Anke Reinacher-Schick, et al. · Clinical Colorectal Cancer · 46
Fast and label-free automated detection of microsatellite status in early colon cancer using artificial intelligence integrated infrared imaging
2023 · Klaus Gerwert, Stephanie Schörner, et al. · European Journal of Cancer · 31
PDF
A framework for falsifiable explanations of machine learning models with an application in computational pathology
2022 · David Schuhmacher, Stephanie Schörner, et al. · Medical Image Analysis · 26
Mental burden and moral distress among oncologists and oncology nurses in Germany during the third wave of the COVID-19 pandemic: a cross-sectional survey
2023 · Sabine Sommerlatte, Celine Lugnier, et al. · Journal of Cancer Research and Clinical Oncology · 18
PDF
PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer
2025 · Susy Shim, Anke Reinacher-Schick, et al. · Investigational New Drugs · 6
PDF
Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients
2023 · Oliver Overheu, Simon Lendowski, et al. · Journal of Cancer Research and Clinical Oncology · 5
PDF
Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry
2022 · Stefanie Nöpel‐Dünnebacke, Hendrick Jütte, et al. · Cancer Medicine · 5
PDF
1641P ABCG transporter and SRPK1 kinase inhibition of chemotherapy resistance: A phase Ib clinical trial of safety and maximum tolerated dose for SCO-101 in combination with gemcitabine and nab-paclitaxel in inoperable pancreatic cancer
2023 · M. Ladekarl, S. Shim, et al. · Annals of Oncology · 3
PDF
What does “urgency” mean when prioritizing cancer treatment? Results from a qualitative study with German oncologists and other experts during the COVID-19 pandemic
2024 · Sabine Sommerlatte, Helene Hense, et al. · Journal of Cancer Research and Clinical Oncology · 2
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice
2022 · Anke Reinacher-Schick, Dirk Arnold, et al. · Oncology Research and Treatment · 2
PDF
Liquid biopsy in patients with metastatic pancreatic cancer using an optimized targeted sequencing approach: Data from the pancreatic cancer registry PanDaDETECT.
2024 · David Witte, Frederick Czaja, et al. · Journal of Clinical Oncology · 1
PDF
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany
2024 · Celine Lugnier, Sabine Sommerlatte, et al. · Oncology Research and Treatment · 1
PDF
407P Cross-sectoral colorectal cancer care in Germany in the context of the COVID-19 pandemic and scarcity of resources
2022 · C. Lugnier, T. Birkner, et al. · Annals of Oncology · 1
385O Automated detection of microsatellite status in early colon cancer (CC) using artificial intelligence (AI) integrated infrared (IR) imaging on unstained samples from the AIO ColoPredictPlus 2.0 (CPP) registry study
2021 · F. Großerüschkamp, S.M. Schörner, et al. · Annals of Oncology · 1
Significant Alterations of Colorectal Cancer Care in the COVID-19 Pandemic With High Adherence to Quality Criteria in German Cancer Centers (CC) ‒ Data From the AIO CancerCOVID Consortium (AIO-YMO/KRK 520/ass)
2025 · Céline Lugnier, Sarah Förster, et al. · Clinical Colorectal Cancer
565P Real-world data of early-onset colon cancer (early-onset CC) from the AIO colopredict plus (CPP) registry: Clinical and molecular characteristics, treatment and outcome
2023 · D.M. Gisder, I. Tischoff, et al. · Annals of Oncology
PDF
Comprehensive analysis of the mutational status of early colon cancer: real world data from the AIO ColoPredict Plus (CPP) registry study
2023 · D. M. Gisder, J. Christmann, et al. · Zeitschrift für Gastroenterologie
Association of guideline adherence in diagnosis and treatment of pancreatic neuroendocrine tumors with survival.
2023 · Oliver Overheu, Doreen M. Gisder, et al. · Journal of Clinical Oncology
PDF
Comprehensive analysis of the mutational status of early colon cancer: Real world data from the AIO ColoPredict registry study.
2023 · Doreen Maria Gisder, Sarah Wisser, et al. · Journal of Clinical Oncology
Impact of vaccine hesitancy on antibody response after SARS-CoV-2 vaccination in patients with cancer.
2023 · Oliver Overheu, Simon Lendowski, et al. · Journal of Clinical Oncology
1333P S1 Guideline for prioritisation in gastrointestinal cancer care: Scarcity of resources in the pandemic context
2022 · A. Reinacher-Schick, C. Lugnier, et al. · Annals of Oncology
PDF
Medizinische Versorgung von Patient:innen unter Ressourcenknappheit am Beispiel der COVID-19 Pandemie mit besonderem Fokus auf kolorektalem Karzinom und Pankreaskarzinom
2022 · O Schoffer, T Birkner, et al. · Das Gesundheitswesen
Label-free and automated approach to rapidly classify microsatellite instability (MSI) in early colon cancer (CC) analyzing the AIO ColoPredictPlus 2.0 (CPP) registry trial.
2022 · Stephanie Schörner, Frederik Großerueschkamp, et al. · Journal of Clinical Oncology
PD-11 In depth analysis of label-free infrared (IR) imaging-based microsatellite instability (MSI) classification in early colon cancer (CC) on samples from the AIO ColoPredictPlus 2.0 (CPP) registry trial
2022 · K. Gerwert, S. Schörner, et al. · Annals of Oncology
PDF
Impact of the COVID-19 pandemic on colorectal cancer (CRC) care: Data from 22 German cancer centers (CC) and the Institute of Pathology, Ruhr-University Bochum - the AIO (Working Group for Internal Oncology of the German Cancer Society) CancerCOVID Consortium - AIO-YMO/KRK 520/ass.
2022 · Celine Lugnier, Sarah Foerster, et al. · Journal of Clinical Oncology
Works count: 30
Citation count: 148
H-index: 5
I10-index: 4
Year
Topic
Type